Search

Ming Yu Phones & Addresses

  • Cerritos, CA
  • Norwalk, CA
  • La Mirada, CA
  • Buena Park, CA

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ming Shan Yu
President
3M8.Org Corporation
17870 Castleton St, Whittier, CA 91748
Ming Yun Yu
President
Greenery Inc
12433 Central Ave, Chino, CA 91710
767 N Hl St, Los Angeles, CA 90012
Ming Yu
President
BUSINESS CASUAL APPAREL
Whol Nondurable Goods Public Relations Services · Ret Women's Clothing · Womens Clothing Stores
2875 Metropolitan Pl, Pomona, CA 91767
109 N Santa Anita Ave, Arcadia, CA 91006
732 N Azusa Ave, Duarte, CA 91702
(626) 815-1630
Ming Yu
President
DUB HARRIS CORPORATION
Packaging & Shipping Services
2875 Metropolitan Pl, Pomona, CA 91767
4675 Macarthur Ct, Newport Beach, CA 92660
(909) 596-6300
Ming Yu
Partner
Coast Electronic Supply
Whol Electronic Parts
12753 Moore St, Artesia, CA 90703
(562) 926-5758
Ming Yu
Manager
Shen Zhen New World II, LLC
Hotel/Motel Operation
333 Universal Hollywood Dr, North Hollywood, CA 91608
20687-2 Amar Rd, Walnut, CA 91789
3 San Joaquin Plz, Newport Beach, CA 92660
2875 Metropolitan Pl, Pomona, CA 91767
Ming Yu
President
HOMECREST, INC
Whol Homefurnishings
6031 Camelia Ave, Temple City, CA 91780
150 N Santa Anita Ave, Arcadia, CA 91006
6031 Camellia Ave, Temple City, CA 91780
(626) 445-8810

Publications

Us Patents

Compounds, Composition, Methods, Targets For Cancer Therapy

View page
US Patent:
20110142815, Jun 16, 2011
Filed:
Jan 4, 2010
Appl. No.:
12/667687
Inventors:
Ming YU - Los Angeles CA, US
International Classification:
A61K 31/41
A61K 38/43
A61K 31/7052
C12N 5/09
A61P 35/00
US Classification:
424 941, 514381, 514 44 A, 435375
Abstract:
This invention describes methods and pharmaceutical compositions for combinational cancer treatments that are capable of inducing JNK phosphorylation and induce programmed cell death. It also identified genes as target for anti-cancer drug development and enhancement of the chemotherapeutic drug effect for the treatment of cancer. This invention points to a novel method and principle for a new avenue of developing more efficient and low or non cytotoxic cancer treatment.

Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer

View page
US Patent:
20110319378, Dec 29, 2011
Filed:
Jun 3, 2011
Appl. No.:
13/153345
Inventors:
Michael David BARTBERGER - Sherman Oaks CA, US
Ana GONZALEZ BUENROSTRO - San Mateo CA, US
Hilary Plake BECK - San Carlos CA, US
Xiaoqi CHEN - Palo Alto CA, US
Richard Victor CONNORS - Pacifica CA, US
Jeffrey DEIGNAN - San Francisco CA, US
Jason DUQUETTE - Millbrae CA, US
John EKSTEROWICZ - San Francisco CA, US
Benjamin FISHER - San Mateo CA, US
Brian Matthew FOX - Brisbane CA, US
Jiasheng FU - Foster City CA, US
Zice FU - Foster City CA, US
Felix GONZALEZ LOPEZ DE TURISO - San Mateo CA, US
Michael GRIBBLE, JR. - San Francisco CA, US
Darin James GUSTIN - Half Moon Bay CA, US
Julie Anne HEATH - Orinda CA, US
Xin HUANG - Wellesley MA, US
Xianyun JIAO - Belmont WA, US
Michael G. JOHNSON - San Francisco CA, US
Frank KAYSER - San Francisco CA, US
David John KOPECKY - San Francisco CA, US
Sujen LAI - Burlingame CA, US
Yihong LI - Millbrae CA, US
Zhihong LI - Millbrae CA, US
Jiwen LIU - Foster City CA, US
Jonathan Dante LOW - Tarzana CA, US
Brian Stuart LUCAS - San Francisco CA, US
Zhihua MA - Foster City CA, US
Lawrence McGEE - Pacifica CA, US
Joel McINTOSH - Pacifica CA, US
Dustin McMINN - Pacifica CA, US
Julio Cesar MEDINA - San Carlos CA, US
Jeffrey Thomas MIHALIC - San Francisco CA, US
Steven Howard Olson - Foster City CA, US
Yosup REW - Foster City CA, US
Philip Marley ROVETO - San Francisco CA, US
Daqing SUN - Foster City CA, US
Xiaodong WANG - Millbrae CA, US
Yingcai WANG - Millbrae CA, US
Xuelei YAN - Foster City CA, US
Ming YU - Foster City CA, US
Jiang ZHU - Palo Alto CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
A61K 31/451
C07D 413/06
A61K 31/5377
C07D 401/06
A61K 31/454
C07D 417/06
A61K 31/541
A61K 31/4545
C07D 413/12
C07D 471/10
A61K 31/438
C07D 409/04
A61K 31/4535
A61K 31/496
C07D 279/02
C07D 498/08
A61K 31/5386
A61K 31/549
C07D 498/16
A61K 31/437
A61P 35/00
C07D 211/40
US Classification:
5142102, 546221, 514327, 544130, 5142355, 546208, 514326, 544 582, 5142278, 546209, 546194, 514318, 546216, 5142372, 546 17, 514278, 546213, 544360, 51425312, 544 3, 5142222, 544105, 5142305, 544 11, 5142228, 546 90, 514291
Abstract:
The present invention provides MDM2 inhibitor compounds of Formula I,

Compounds, Composition, Methods, Targets For Cancer Therapy

View page
US Patent:
20170081662, Mar 23, 2017
Filed:
Sep 26, 2016
Appl. No.:
15/275863
Inventors:
Ming Yu - Los Angeles CA, US
International Classification:
C12N 15/113
Abstract:
This invention points to biological molecules and/or sequences that can be used as target for designing drug for treating cancer. This invention also points to biological sequences that can be used to target those molecules as a mean to treat cancer.

Compounds, Composition, Methods, Targets For Cancer Therapy

View page
US Patent:
20140163088, Jun 12, 2014
Filed:
Jan 9, 2014
Appl. No.:
14/151539
Inventors:
Ming YU - Los Angeles CA, US
International Classification:
A61K 31/713
A61K 45/06
A61K 31/47
C07D 257/04
A61K 31/41
US Classification:
514 44 A, 548252, 514381
Abstract:
This invention describes methods and pharmaceutical compositions for combinational cancer treatments that are capable of inducing JNK phosphorylation and induce programmed cell death. It also identified genes as target for anti-cancer drug development and enhancement of the chemotherapeutic drug effect for the treatment of cancer. This invention points to a novel method and principle for a new avenue of developing more efficient and low or non cytotoxic cancer treatment.
Ming Yu Yu from Cerritos, CA, age ~65 Get Report